title: Superoxide dismutase does not cause scar thinning after myocardial infarction.
abstract: Previous studies demonstrated that treatment with superoxide dismutase, a scavenger of superoxide anions, limits the extent of myocardial injury in a canine preparation of regional myocardial ischemia and reperfusion. Little is known, however, about the effects of superoxide dismutase on the healing of a myocardial infarct. Therefore, this study was performed to determine whether treatment with superoxide dismutase during myocardial ischemia impairs formation of scar tissue after infarction. Dogs received 2 hour infusions of superoxide dismutase or albumin (controls) by way of the left atrium beginning 15 minutes before and ending 15 minutes after a 90 minute occlusion of the left circumflex coronary artery. Six weeks later the animals were killed. Two-dimensional echocardiography was performed before surgery and before induced death. Wall thickening in the central ischemic zone was decreased at 6 weeks compared with baseline studies (p less than 0.05), but the decrease was similar for both groups. The hydroxyproline concentrations (microgram/mg dry weight) of the scar tissue in the superoxide dismutase and control groups, respectively, were 35.3 +/- 3.8 and 28.7 +/- 5.0 (p less than 0.05). The ratios of the scar thickness to normal wall thickness were superoxide dismutase 0.91 +/- 0.03 and control 0.89 +/- 0.03 (p greater than 0.05). Thus, superoxide dismutase had no adverse effect on wall thickening or scar formation assessed 6 weeks after myocardial infarction, and may be useful to limit oxygen radical-mediated damage during reperfusion of the ischemic myocardium.
mesh_terms: D000818:Animals; D002921:Cicatrix / Q000517:prevention & control; D004285:Dogs; D004452:Echocardiography; D006097:Granulation Tissue / Q000032:analysis / Q000187:drug effects*; D006909:Hydroxyproline / Q000032:analysis; D008297:Male; D009203:Myocardial Infarction / Q000503:physiopathology*; D011897:Random Allocation; D012710:Serum Albumin, Bovine / Q000627:therapeutic use; D013482:Superoxide Dismutase / Q000627:therapeutic use*
chemical_list: D012710:Serum Albumin, Bovine; D013482:Superoxide Dismutase; D006909:Hydroxyproline